Aberdeen, Scotland – EnteroBiotix, a privately held Scottish biotechnology company focused on using the body’s own microorganisms to prevent and treat disease, today announced that the Company’s CEO, James McIlroy, was awarded the title of ‘Emerging Entrepreneur of the Year’ at the 2017 BQ National Entrepreneur Festival.

Hosted by BQ and powered by Atom Bank, the awards brought together entrepreneurs from across the UK with the challenge of identifying individuals who, in the view of the judges, are part of the next generation of successful entrepreneurs.

The Scottish award was supported by Scottish Institute for Enterprise. CEO Fiona Godsman said:

“Scotland’s historic contribution to innovation both in the UK and the wider world is widely known. We’re very proud of the next generation of Scottish innovators at SIE and we’re very pleased to help showcase some of our brightest new talent on the national stage. The Scottish winner, James McIlroy, is an excellent example of someone using entrepreneurship to solve a real problem. He’s made great strides with EnteroBiotix which has already gained significant traction and investment”

For further information, please see the official article on the BQ Website.

About EnteroBiotix

EnteroBiotix is a patient-centred biotechnology company developing novel medicinal products for use in infections or diseases associated with imbalances of bacteria in the human gut. The Company has established, staffed and integrated an ISO-accredited controlled donation facility and a fully equipped state-of-the-art manufacturing facility to manage collection, processing and formulation of medicinal products derived from healthy human donations. Headquartered in Aberdeen, EnteroBiotix has raised £700,000 in equity investment and non-dilutive funding with a dedicated core team of seven supported an Independent Scientific and Medical Advisory Board.

For further information, please contact:

James McIlroy, CEO



Recommended Posts